Publicaciones - IR Sant Pau

Buscar

01/08/2025 Pretransplant Clusters and Outcomes Determining Variables of Expanded Criteria Donors Controlled Donation After Circulatory Death Kidney Transplants through a Hybrid Artificial Intelligence-Based Model Combining Survival Analysis, Multiple Criteria Optimization and an Artificial Neural Network

Santos-Arteaga, F, Di Caprio, D, Montero, N, Toapanda, N, Crespo, M, Facundo, C, Melilli, E, Cucchiari, D, Moreso, F, Anna, B, Perich, LG, Diekmann, F, Cruzado, J, Bestard, O, Revuelta, I. Pretransplant Clusters and Outcomes Determining Variables of Expanded Criteria Donors Controlled Donation After Circulatory Death Kidney Transplants through a Hybrid Artificial Intelligence-Based Model Combining Survival Analysis, Multiple Criteria Optimization and an Artificial Neural Network. AMERICAN JOURNAL OF TRANSPLANTATION. 2025; 25(8)DOI:. PMID:. IF:8.200(Q1/1D).

23/07/2025 Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data

Rua-Figueroa, I, Cervera, R, Freire-González, M, Nieves, AIT, Cortes-Hernández, J, Castellvi, I, Ajo, JB, Salman, T, Alén, JC, Lozano-Rivas, N, Ortego-Centeno, N, Diaz-Encarnación, M, Ding, B, Galvez-Fernandez, M, Bahamontes-Rosa, N, Pego-Reigosa, JM, Spanish SLE Prospective Observational Cohort Study SPOCS. Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data. Lupus Science & Medicine. 2025; 12(2)DOI:10.1136/lupus-2025-001597. PMID:40701627. IF:3.500(Q2/3D).

03/07/2025 Innovative management of BK virus nephropathy post-HSCT: a case report and therapeutic insights

Vallvé, M, Pasache, K, Castillo, N, Domínguez, A, Esquirol, A, Martino, R, Guirado, L, Arce, Y, Barros, X, García-Cadenas, I. Innovative management of BK virus nephropathy post-HSCT: a case report and therapeutic insights. LEUKEMIA & LYMPHOMA. 2025; 66(8)DOI:10.1080/10428194.2025.2480394. PMID:40127134. IF:2.200(Q3/6D).

01/07/2025 A call for urgent action on chronic kidney disease across Europe

Ferro, CJ, Wanner, C, Luyckx, V, Fontana, M, Gallego, D, Vanholder, R, Torra, R, Ortiz, A. A call for urgent action on chronic kidney disease across Europe. Lancet Regional Health-Europe. 2025; 54DOI:10.1016/j.lanepe.2025.101347. PMID:40548327. IF:13.000(Q1/1D).

27/06/2025 High HLA Sensitization After Early Renal Allograft Vascular Thrombosis

Pérez-Sáez, MJ, Comas, J, Melilli, E, Moreso, F, Guirado, L, Vila, A, Diekmann, F, Palou, E, Tort, J, Redondo-Pachón, D, Crespo, M. High HLA Sensitization After Early Renal Allograft Vascular Thrombosis. TRANSPLANT INTERNATIONAL. 2025; 38DOI:10.3389/ti.2025.14457. PMID:40656559. IF:3.000(Q1/1D).

13/06/2025 Magnesium Balance in Chronic Kidney Disease: Mineral Metabolism, Immunosuppressive Therapies and Sodium-Glucose Cotransporter 2 Inhibitors

Díaz-Tocados, JM, Lloret, MJ, Domínguez-Coral, JD, Aranda, APT, de Arizón, LF, Jiménez, EM, Bover, J, Valdivielso, JM, Rodríguez-Ortiz, ME. Magnesium Balance in Chronic Kidney Disease: Mineral Metabolism, Immunosuppressive Therapies and Sodium-Glucose Cotransporter 2 Inhibitors. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(12)DOI:10.3390/ijms26125657. PMID:40565121. IF:4.900(Q1/3D).

01/06/2025 CHALLENGES IN SYSTEMIC LUPUS ERYTHEMATOSUS IN SPANISH SPOCS SUB-COHORT OF MODERATE-SEVERE PATIENTS

Rúa-Figueroa, IJ, González, MF, Salman-Monte, TC, Segura, RC, Turrión, AI, Castellv, I, Alén, JC, Ajo, JB, Díaz, M, Ortego-Centeno, N, Rivas, NL, Cortés-Hernández, J, Alvarez-Hernández, P, Galvez-Fernandez, M, Bahamontes, N, Ding, B, Pego-Reigosa, JM. CHALLENGES IN SYSTEMIC LUPUS ERYTHEMATOSUS IN SPANISH SPOCS SUB-COHORT OF MODERATE-SEVERE PATIENTS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2398. PMID:. IF:20.600(Q1/1D).

01/06/2025 Diagnosis, management and treatment of the Alport syndrome-2024 guideline on behalf of ERKNet, ERA and ESPN

Torra, R, Lipska-Zietkiewicz, B, Acke, F, Antignac, C, Becker, JU, Gall, ECL, van Eerde, AM, Feltgen, N, Ferrari, R, Gale, DP, Gear, S, Gross, O, Hebaerle, S, Heidet, L, Lennon, R, Massella, L, Pfau, K, Pizarro, MDV, Topaloglu, R, Wlodkowski, T, Zealey, H. Diagnosis, management and treatment of the Alport syndrome-2024 guideline on behalf of ERKNet, ERA and ESPN. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40(6)DOI:10.1093/ndt/gfae265. PMID:39673454. IF:5.600(Q1/1D).

01/05/2025 A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study

Bermejo, S, González, E, López-Revuelta, K, Ibernon, M, López, D, Martín-Gómez, A, Garcia-Osuna, R, Linares, T, Díaz, M, Martín, N, Barros, X, Marco, H, Navarro, MI, Esparza, N, Elias, S, Coloma, A, Robles, NR, Agraz, I, Poch, E, Rodas, L, Lozano, V, Fernández-Fernández, B, Hernández, E, Martínez, MI, Stanescu, RI, Moirón, JP, García-Fernández, N, Goicoechea, M, Calero, F, Bonet, J, Liaño, F, Pascual, J, Praga, M, Fulladosa, X, Soler, MJ. A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study. NEFROLOGIA. 2025; 45(5)DOI:10.1016/j.nefro.2024.12.007. PMID:40518653. IF:2.600(Q2/4D).

01/05/2025 Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group

Geertsema, P, Gansevoort, RT, Arici, M, Capasso, G, Gall, ECL, Furlano, M, Fuster, DG, Galletti, F, Dos Santos, VG, Gomez, MVP, Goumenos, D, Halbritter, J, Jambon, E, Korst, U, Leliveld-Kors, AM, Musquera, M, Figueiredo, A, Nijenhuis, T, Olsburgh, J, Pol, RA, Sayer, JA, Stippel, D, Torra, R, Müller, RU, Casteleijn, NF. Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40(5)DOI:10.1093/ndt/gfaf019. PMID:39848914. IF:5.600(Q1/1D).

01/05/2025 Inherited kidney disease and CAKUT are common causes of kidney failure requiring kidney replacement therapy: an ERA Registry study

Ortiz, A, Kramer, A, Ariceta, G, Arevalo, OLR, Gjerstad, AC, Santiuste, C, Trujillo-Aleman, S, Ferraro, PM, Methven, S, Santamaria, R, Naumovic, R, Resic, H, Hommel, K, Segelmark, M, Ambuehl, PM, Sorensen, SS, Parmentier, C, Vidal, E, Bakkaloglu, SA, Plumb, L, Palsson, R, Kerschbaum, J, ten Dam, MAGJ, Stel, VS, Jager, KJ, Torra, R. Inherited kidney disease and CAKUT are common causes of kidney failure requiring kidney replacement therapy: an ERA Registry study. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40(5)DOI:10.1093/ndt/gfae240. PMID:39508350. IF:5.600(Q1/1D).

18/04/2025 Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies

García-Aznar, JM, Besada-Cerecedo, ML, Castro-Alonso, C, Carpio, MS, Blasco, M, Quiroga, B, Cervienka, M, Mouzo, R, Torra, R, Ortiz, A, de Sequera, P. Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies. Genes. 2025; 16(4)DOI:10.3390/genes16040464. PMID:40282423. IF:2.800(Q2/5D).

01/04/2025 Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140

Zagorec, N, Calamel, A, Delaporte, M, Olinger, E, Orr, S, Sayer, JA, Pillay, VG, Denommé-Pichon, AS, Mau-Them, FT, Nambot, S, Faivre, L, Ars, E, Torra, R, Ong, ACM, Devuyst, O, Perico, N, Després, AM, Lemoine, H, de Fallois, J, Brousse, R, Hummel, A, Knebelmann, B, Maisonneuve, N, Halbritter, J, Le Meur, Y, Audrézet, MP, Cornec-Le Gall, E. Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140. AMERICAN JOURNAL OF KIDNEY DISEASES. 2025; 85(4)DOI:10.1053/j.ajkd.2024.10.009. PMID:39732359. IF:8.200(Q1/1D).

01/04/2025 Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies

Gauckler, P, Matyjek, A, Kapsia, S, Marinaki, S, Quintana, LF, Diaz, MM, King, C, Griffin, S, Ramachandran, R, Odler, B, Eller, K, Artan, AS, Mirioglu, S, Busch, M, Schaepe, M, Turkmen, K, Cheung, CK, Pepper, RJ, Juarez, GF, Pascual, J, Aunon, P, García-Carro, C, Rodriguez, A, Alberici, F, Luzardo, L, Chebotareva, N, Schönermarck, U, Fernández, L, Radhakrishnan, J, Guaman, K, Peleg, Y, Hoisnard, L, Audard, V, Papasotiriou, M, Krnanska, N, Tesar, V, Hruskova, Z, Bruchfeld, A, Stangou, M, Lioulios, G, Faguer, S, Ribes, D, Salhi, S, Windpessl, M, Galesic, K, Crnogorac, M, Zagorec, N, Mayer, G, Kronbichler, A. Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025; 36(4)DOI:10.1681/ASN.0000000520. PMID:39431468. IF:9.400(Q1/1D).

01/04/2025 Study of bone turnover biomarker behavior within the first year post-kidney transplant

Lloret, MJ, Canal, C, Montañés, R, Di Gregorio, S, Arizón, LFD, Tinoco, A, Laiz, A, Montolio, D, Facundo, C, Guirado, L, Bover, J. Study of bone turnover biomarker behavior within the first year post-kidney transplant. Revista De Osteoporosis Y Metabolismo Mineral. 2025; 17(2)DOI:10.20960/RevOsteoporosMetabMiner.00063. PMID:. IF:(Q/D).

20/03/2025 When should the nephrologist think about genetics in patients with glomerular diseases?

Torra, R, Barros, X, Díaz-Encarnación, M, Fayos, L, Furlano, M, Pilco, M, Pybus, M, Shabaka, A, Viera, E, Ars, E. When should the nephrologist think about genetics in patients with glomerular diseases?. Clinical Kidney Journal. 2025; 18(3)DOI:10.1093/ckj/sfaf044. PMID:40115110. IF:4.600(Q1/2D).

12/03/2025 Highlights from the breakout session: advances in treatment II

Segelmark, M, Díaz, M. Highlights from the breakout session: advances in treatment II. RHEUMATOLOGY. 2025; 64DOI:10.1093/rheumatology/keae421. PMID:40071411. IF:4.400(Q1/1D).

04/03/2025 Genetic vs non-genetic kidney disease: prognosis insights from a multi-cohort study

Dirim, AB, Torra, R. Genetic vs non-genetic kidney disease: prognosis insights from a multi-cohort study. Clinical Kidney Journal. 2025; 18(3)DOI:10.1093/ckj/sfaf033. PMID:40046818. IF:4.600(Q1/2D).

20/02/2025 Quality of life and clinical data in hemodialysis patients with different degrees of pruritus

Fontao, SM, Manso, P, Audije-Gil, J, Gascueña, DH, Dapena, F, Aresté, N, Sánchez-Alvarez, E, Molina, P, Ojeda, R, Goicoechea, M, Simó, VE, Bezhold, GA, Prieto-Velasco, M, Lloret, MJ, Santos, AB, Buades, JM, Narváez, C, Sánchez-Villanueva, R, Pérez-Morales, RE, Jiménez, MDA. Quality of life and clinical data in hemodialysis patients with different degrees of pruritus. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-024-83833-2. PMID:39979317. IF:3.900(Q1/2D).

12/02/2025 Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses

Gutzeit, C, Grasset, EK, Matthews, DB, Maglione, PJ, Britton, GJ, Miller, H, Magri, G, Tomalin, L, Stapylton, M, Canales-Herrerias, P, Sominskaia, M, Guzman, M, Pybus, M, Vaquero, ST, Radigan, L, Tachó-Piñot, R, Nalda, AM, Prat, MG, Gallo, MM, Dieli-Crimi, R, Clemente, JC, Mehandru, S, Suarez-Farinas, M, Faith, JJ, Cunningham-Rundles, C, Cerutti, A. Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses. Science Advances. 2025; 11(7)DOI:10.1126/sciadv.ado9455. PMID:39937896. IF:12.500(Q1/1D).

01/02/2025 KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary

Torres, VE, Ahn, C, Barten, TRM, Brosnahan, G, Cadnapaphornchai, MA, Chapman, AB, Cornec-Le Gall, E, Drenth, JPH, Gansevoort, RT, Harris, PC, Harris, T, Horie, S, Liebau, MC, Liew, M, Mallett, AJ, Mei, CL, Mekahli, D, Odland, D, Ong, ACM, Onuchic, LF, Pei, YPC, Perrone, RD, Rangan, GK, Rayner, B, Torra, R, Balk, EM, Gordon, CE, Earley, A, Mustafa, RA, Devuyst, O. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. KIDNEY INTERNATIONAL. 2025; 107(2)DOI:10.1016/j.kint.2024.07.010. PMID:39848746. IF:12.600(Q1/1D).

07/01/2025 Clinical management of female patients with Fabry disease based on expert consensus

Brand, E, Linhart, A, Deegan, P, Jurcut, R, Pisani, A, Torra, R, Feldt-Rasmussen, U. Clinical management of female patients with Fabry disease based on expert consensus. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03500-7. PMID:39773286. IF:3.500(Q2/4D).

01/01/2025 Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry

Hughes, DA, Sunder-Plassmann, G, Jovanovic, A, Brand, E, West, ML, Bichet, DG, Pisani, A, Nowak, A, Torra, R, Khan, A, Azevedo, O, Lehman, A, Linhart, A, Rutecki, J, Giuliano, JD, Krusinska, E, Nordbeck, P. Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry. JOURNAL OF INHERITED METABOLIC DISEASE. 2025; 48(1)DOI:10.1002/jimd.12771. PMID:39031114. IF:3.800(Q2/3D).

01/01/2025 Genetic determinants of testicular sperm extraction outcomes: insights from a large multicentre study of men with non-obstructive azoospermia

Riera-Escamilla, A, Arafa, MM, Farnetani, G, Xavier, MJ, Oud, MS, Majzoub, AA, Ramos, L, Abrardo, C, Spinelli, M, Moreno-Mendoza, D, Defazio, G, Ars, E, Pybus, M, Curbelo, JRS, Elbardisi, HT, Nawaz, S, Syed, N, Ruiz-Castané, E, van der Heijden, GW, Fakhro, KA, Veltman, JA, Krausz, C. Genetic determinants of testicular sperm extraction outcomes: insights from a large multicentre study of men with non-obstructive azoospermia. Human Reproduction Open. 2025; 2025(3)DOI:10.1093/hropen/hoaf049. PMID:40896145. IF:11.100(Q1/1D).

01/12/2024 Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study

Blasco, M, Quiroga, B, García-Aznar, JM, Castro-Alonso, C, Fernández-Granados, SJ, Luna, E, Fresnedo, GF, Ossorio, M, Izquierdo, MJ, Sanchez-Ospina, D, Castañeda-Infante, L, Mouzo, R, Cao, M, Besada-Cerecedo, ML, Pan-Lizcano, R, Torra, R, Ortiz, A, de Sequera, P. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study. AMERICAN JOURNAL OF KIDNEY DISEASES. 2024; 84(6)DOI:10.1053/j.ajkd.2024.04.021. PMID:38972501. IF:8.200(Q1/1D).

01/12/2024 Intradialytic Parenteral Nutrition in Patients on Hemodialysis: A Multicenter Retrospective Study

Arias-Guillén, M, González, JC, Betancourt, L, Coll, E, Collado, S, Romano-Andrioni, B, Lupiañez-Barbero, A, Garro, J, Duarte, V, Soler-Majoral, J, Calabia, J. Intradialytic Parenteral Nutrition in Patients on Hemodialysis: A Multicenter Retrospective Study. Nutrients. 2024; 16(23)DOI:10.3390/nu16234018. PMID:39683411. IF:5.000(Q1/2D).

01/11/2024 Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome

El Bachouti, J, Domínguez-Guasch, A, Arce, Y, Oñate, G, Marco, H, Diaz, M, Guirado, L, Torra, R, Barros, X. Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216468. PMID:39518607. IF:2.900(Q1/2D).

01/11/2024 Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease

Coll, E, Cigarran, S, Portolés, J, Cases, A. Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease. Toxins. 2024; 16(11)DOI:10.3390/toxins16110495. PMID:39591250. IF:4.000(Q1/3D).

01/11/2024 Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT)

Draibe, JB, Marco, H, Ibernon, M, Agraz, I, Arcal, C, Barros, X, Cabrera, V, Da Silva, I, Díaz, M, Fulladosa, X, Guillén, E, Lescano, P, Valenzuela, LM, Márquez, E, Martin, N, Merino, A, Navarro, M, Rodríguez, E, Soler, MJ, Torras, J, Quintana, LF. Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT). Journal of Clinical Medicine. 2024; 13(22)DOI:10.3390/jcm13226793. PMID:39597938. IF:2.900(Q1/2D).

01/09/2024 Long-term outcome of NPHS2-related glomerulopathy

Lipska, B, Hofstetter, J, Trautmann, A, Boyer, O, Saleem, M, Tory, K, Ars, E, Dorval, G, Schaefer, F. Long-term outcome of NPHS2-related glomerulopathy. PEDIATRIC NEPHROLOGY. 2024; 39(1)DOI:. PMID:. IF:2.600(Q1/2D).

01/09/2024 Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework

Duijzer, R, Bernts, LHP, Geerts, A, van Hoek, B, Coenraad, MJ, Rovers, C, Alvaro, D, Kuijper, EJ, Nevens, F, Halbritter, J, Colmenero, J, Kupcinskas, J, Salih, M, Hogan, MC, Ronot, M, Vilgrain, V, Hanemaaijer, NM, Kamath, PS, Strnad, P, Taubert, R, Gansevoort, R, Torra, R, Nadalin, S, Suwabe, T, Gevers, TJG, Cardinale, V, Drenth, JPH, Lantinga, MA. Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00094-3. PMID:38878785. IF:38.600(Q1/1D).

01/07/2024 Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN

Blasco M., Quiroga B., García-Aznar J.M., Torra R., Ortiz A., de Sequera P.. Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN. NEFROLOGIA. 2024; 44(4)DOI:10.1016/j.nefro.2023.09.002. PMID:39054238. IF:2.600(Q2/4D).

01/07/2024 Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data

Salgueira, M, Almenara, M, Gutierrez-Pizarraya, A, Belmar, L, Labrador, PJ, Melero, R, Serrano, ML, Portoles, JM, Molina, A, Poch, E, Ramos, N, Lloret, MJ, Echarri, R, Mancebo, RD, Gonzalez-Lara, DM, Sanchez, JE, Soler, MJ. Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data. NEFROLOGIA. 2024; 44(4)DOI:10.1016/j.nefro.2023.03.008. PMID:. IF:2.600(Q2/4D).

30/05/2024 Ten tips on how to assess bone health in patients with chronic kidney disease

Jorgensen, HS, Lloret, MJ, Lalayiannis, AD, Shroff, R, Evenepoel, P. Ten tips on how to assess bone health in patients with chronic kidney disease. Clinical Kidney Journal. 2024; 17(5)DOI:10.1093/ckj/sfae093. PMID:38817914. IF:4.600(Q1/2D).

23/05/2024 Fibrosis and CD-163+macrophages: making a difference between MPO-AAV and PR3-AAV

Benito-Garcia, S, Vilardell, J, Arce, Y, Barros, X, Marco, H, Guirado, L, Encarnacion, MMD. Fibrosis and CD-163+macrophages: making a difference between MPO-AAV and PR3-AAV. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.324. PMID:. IF:5.600(Q1/1D).

23/05/2024 Comparative analysis of vitamin D status between patients with advanced chronic kidney disease and those on dialysis

Delgado, CM, Rodríguez, DL, Navarro-González, JF, Henriquez, F, Gilsanz, GD, Prieto, FJT, Jesus, LM, Morales, OS, Macia, M. Comparative analysis of vitamin D status between patients with advanced chronic kidney disease and those on dialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.1481. PMID:. IF:5.600(Q1/1D).

23/05/2024 ERCOS multicenter Spanish study: clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis

Jiménez, EM, Sanjuan, JB, Casado, E, García, MR, Lloret, MJ, Alonso, CC, Henriquez, F, Gifre, L, Calvo, JAH, Teruel, JLG, Gómez, C, Navarro-González, JF. ERCOS multicenter Spanish study: clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.1471. PMID:. IF:5.600(Q1/1D).

23/05/2024 Impact of dialysis modality on bone phenotype

Lloret, MJ, Jorgensen, HS, Verhulst, A, Bammens, B, Claes, K, Devusser, K, Meijers, B, Van Craenenbroeck, A, De Loor, J, Cavalier, E, Evenepoel, P. Impact of dialysis modality on bone phenotype. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.856. PMID:. IF:5.600(Q1/1D).

23/05/2024 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)

Brigl, C, Münster, J, Arjune, S, Demoulin, N, Gansevoort, R, Torra, R, Sans, L, Pamplona, IA, Sayer, J, Cornec-Le Gall, E, Hwang, DY, Halbritter, J. Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*). NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.005. PMID:. IF:5.600(Q1/1D).

01/05/2024 Different patterns of renal thrombotic microangiopathy

Guasch, AD, Arce, Y, El Bachouti, J, Tinoco, A, Pasache, HK, Basantes, AC, Marco, H, Torra, R, Guirado, L, Encarnacion, MMD, Barros, X. Different patterns of renal thrombotic microangiopathy. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.300. PMID:. IF:5.600(Q1/1D).

01/05/2024 Preimplantation genetic testing in inherited kidney diseases

Furlano, M, Tinoco, A, Sampani, E, Almeida, C, Goncalves, PL, Polo, A, Martínez, O, Teran, MP, Ramírez, ERV, Ars, E, Torra, R. Preimplantation genetic testing in inherited kidney diseases. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:. PMID:. IF:5.600(Q1/1D).

01/05/2024 Extent of proteinuria in autosomal dominant Alport syndrome compared to X linked Alport syndrome

Goncalves, PL, de Faria, VP, Furlano, M, Almeida, C, Sampani, E, Teran, MP, Viera, E, Fayos, L, Pybus, M, Aza, M, Ars, E, Torra, R. Extent of proteinuria in autosomal dominant Alport syndrome compared to X linked Alport syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.245. PMID:. IF:5.600(Q1/1D).

01/05/2024 Is class II lupus nephritis as benign as one thinks?

Goncalves, PL, Redondo, GB, Arce, Y, Magallares, B, Castellvi, I, Pasache, HK, Dominguez, A, Barros, X, Rusiñol, HM, Encarnacion, MMD. Is class II lupus nephritis as benign as one thinks?. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.356. PMID:. IF:5.600(Q1/1D).

01/05/2024 Factors affecting disease progression in individuals with heterozygous COL4A3/COL4A4 pathogenic variants

Teran, MP, Furlano, M, Pybus, M, Jiménez, VM, Gomá-Garcés, E, Carrillo, IG, Leon, R, Romeo, MJS, de Arizón, LF, Perera, A, Ars, E, Torra, R. Factors affecting disease progression in individuals with heterozygous COL4A3/COL4A4 pathogenic variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:. PMID:. IF:5.600(Q1/1D).

01/05/2024 Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants

Zagorec, N, Calamel, A, Ars, E, Ong, A, Halbritter, J, Audrezet, MP, Pillay, VG, Meur, YL, Sayer, J, Cornec-Le Gall, E. Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.119. PMID:. IF:5.600(Q1/1D).

01/05/2024 Reassuring pregnancy outcomes in women with mild COL4A3-5 - related disease (Alport syndrome) and genetic type of disease can aid personalized counseling

Gosselink, ME, Snoek, R, Cerkauskaite-Kerpauskiene, A, van Bakel, SPJ, Vollenberg, R, Groen, H, Cerkauskiene, R, Miglinas, M, Attini, R, Tory, K, Claes, KJ, van Calsteren, K, Servais, A, de Jong, MFC, Gillion, V, Vogt, L, Mastrangelo, A, Furlano, M, Torra, R, Bramham, K, Wiles, K, Ralston, ER, Hall, M, Liu, LS, Hladunewich, MA, Lely, AT, van Eerde, AM. Reassuring pregnancy outcomes in women with mild COL4A3-5 - related disease (Alport syndrome) and genetic type of disease can aid personalized counseling. KIDNEY INTERNATIONAL. 2024; 105(5)DOI:10.1016/j.kint.2024.01.034. PMID:38382843. IF:12.600(Q1/1D).

05/04/2024 Kidney health matters: a global imperative for public health

Torra, R. Kidney health matters: a global imperative for public health. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39(9)DOI:10.1093/ndt/gfae083. PMID:38578651. IF:5.600(Q1/1D).

01/03/2024 Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica

Bover J., Gómez-Alonso C., Casado E., Rodríguez-García M., Lloret M.J., Castro-Alonso C., Gifre L., Henríquez-Palop F., Prior-Español Á., López de la Manzanara V., Láiz A.M., Martínez-Ferrer À., Torregrosa J.V., Cigarrán S., Górriz J.L., Montomoli M., Panizo N., Costa E., Martínez-Laguna D., Rodríguez M., Navarro-González J.F.. Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefro.2023.05.002. PMID:38531765. IF:2.600(Q2/4D).

01/03/2024 Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?

Lloret, MJ, Jorgensen, HS, Evenepoel, P. Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?. Clinical Kidney Journal. 2024; 17(3)DOI:10.1093/ckj/sfae048. PMID:38500493. IF:4.600(Q1/2D).

01/03/2024 Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care

Bover, J, Gómez-Alonso, C, Casado, E, Rodríguez-García, M, Lloret, MJ, Castro-Alonso, C, Gifre, L, Henríquez-Palop, F, Prior-Español, A, de la Manzanara, VL, Láiz, AM, Martínez-Ferrer, A, Torregrosa, JV, Cigarrán, S, Górriz, JL, Montomoli, M, Panizo, N, Costa, E, Martínez-Laguna, D, Rodríguez, M, Navarro-González, JF. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefroe.2024.03.005. PMID:. IF:2.600(Q2/4D).

14/02/2024 HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial

Bais, T, Meijer, E, Kramers, BJ, Vart, P, Vervloet, M, Salih, M, Bammens, B, Demoulin, N, Todorova, P, Müller, RU, Halbritter, J, Paliege, A, Gall, ECL, Knebelmann, B, Torra, R, Ong, ACM, Frankl, FEK, Gansevoort, RT. HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials. 2024; 25(1)DOI:10.1186/s13063-024-07952-x. PMID:38355627. IF:2.000(Q3/7D).

01/02/2024 Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter

Lloret, MJ, Fusaro, M, Jorgensen, HS, Haarhaus, M, Gifre, L, Alfieri, CM, Masso, E, D'Marco, L, Evenepoel, P, Bover, J. Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter. Journal of Clinical Medicine. 2024; 13(4)DOI:10.3390/jcm13041010. PMID:38398323. IF:2.900(Q1/2D).

04/01/2024 Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective

Lomonte, C, Rossini, M, Ibeas, J, Forcella, M, Ponikvar, JB, Gallieni, M, Russo, R, Goumenos, D, Tesar, V, Hruskova, Z, Roelofs, J, Florquin, S, Snoeijs, M, Giusto, A, Shemesh, D, Rotmans, J, Torra, R, Wanner, C, Gesualdo, L. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective. Clinical Kidney Journal. 2024; 17(1)DOI:10.1093/ckj/sfad299. PMID:38213498. IF:4.600(Q1/2D).

01/01/2024 An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD

Taylor J., Thomas R., Metherall P., van Gastel M., Cornec-Le Gall E., Caroli A., Furlano M., Demoulin N., Devuyst O., Winterbottom J., Torra R., Perico N., Le Meur Y., Schoenherr S., Forer L., Gansevoort R.T., Simms R.J., Ong A.C.M.. An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD. Kidney International Reports. 2024; 9(2)DOI:10.1016/j.ekir.2023.10.029. PMID:38344736. IF:5.700(Q1/1D).

01/01/2024 Influence of primary kidney disease in Chronic Kidney Disease pregnancies: pregnancy outcomes in women with COL4A3-5 related disease (Alport Syndrome)

Gosselink, M, Snoek, R, Cerkauskaite-Kerpauskiene, A, Van Bakel, S, Vollenberg, R, Groen, H, Cerkauskiene, R, Miglinas, M, Attini, R, Tory, K, Claes, K, Van Calsteren, K, Servais, A, de Jong, M, Gillion, V, Vogt, L, Mastrangelo, A, Furlano, M, Torra, R, Bramham, K, Wiles, K, Ralston, E, Hall, M, O'Neill, R, Hladunewich, M, Lely, T, van Eerde, AM. Influence of primary kidney disease in Chronic Kidney Disease pregnancies: pregnancy outcomes in women with COL4A3-5 related disease (Alport Syndrome). EUROPEAN JOURNAL OF HUMAN GENETICS. 2024; 32DOI:. PMID:. IF:4.600(Q1/2D).

01/01/2024 Acute kidney injury (AKI): Spanish nomenclature also matters here

Bover, J, Romero-González, G, Chávez-Iñiguez, JS, Rizo-Topete, L, Graterol, F, Santandreu, AV, Sanchez-Baya, M, Díaz, JM, Ortiz, A, Poch, YE. Acute kidney injury (AKI): Spanish nomenclature also matters here. NEFROLOGIA. 2024; 44(1)DOI:https://doi.org/10.1016/j.nefroe.2024.02.009. PMID:. IF:2.600(Q2/4D).

25/12/2023 A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

Macia, M, Díaz-Encarnación, M, Solans-Laqué, R, Mallol, EP, Castells, AG, Escribano, C, de Arellano, AR. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain. Expert Review of Pharmacoeconomics & Outcomes Research. 2023; 24(2)DOI:10.1080/14737167.2023.2297790. PMID:38126738. IF:1.800(Q3/6D).

09/11/2023 Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!

Torra, R, Kronbichler, A, Bajema, IM. Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!. Clinical Kidney Journal. 2023; 17(1)DOI:10.1093/ckj/sfad250. PMID:38186890. IF:3.900(Q1/2D).

01/10/2023 On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome

Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Cavero T., Fernandez-Cusicanqui J., Blasco M., Cabello V., Calvo N., Diaz M., Herrero-Goñi M., Aguirre M., Elías S., Alcaide M.P., Ramos N., Sellares J., Rodríguez de Córdoba S.. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4)DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14.800(Q1/1D).

29/09/2023 Treatment and long-term outcome in primary nephrogenic diabetes insipidus

Lopez-Garcia, SC, Downie, ML, Kim, JS, Boyer, O, Walsh, SB, Nijenhuis, T, Papizh, S, Yadav, P, Reynolds, B, Decramer, S, Besouw, M, Carrascosa, MP, La Scola, C, Trepiccione, F, Ariceta, G, Hummel, A, Dossier, C, Sayer, JA, Konrad, M, Keijzer-Veen, MG, Awan, A, Basu, B, Chauveau, D, Madariaga, L, Koster-Kamphuis, L, Furlano, M, Zacchia, M, Marzuillo, P, Tse, Y, Dursun, I, Pinarbasi, AS, Tramma, D, Hoorn, EJ, Gokce, I, Nicholls, K, Eid, LA, Sartz, L, Riordan, M, Hooman, N, Printza, N, Bonny, O, Sancho, PA, Schild, R, Sinha, R, Guarino, S, Jimenez, VM, Peña, LR, Belge, H, Devuyst, O, Wlodkowski, T, Emma, F, Levtchenko, E, Knoers, NVAM, Bichet, DG, Schaefer, F, Kleta, R, European NDI Consortium, Bockenhauer, D. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(10)DOI:10.1093/ndt/gfaa243. PMID:33367818. IF:4.800(Q1/2D).